
|Videos|October 24, 2015
Controlled Substance Red Flags
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to prescriptions that can lead to administrative action from the DEA.
Advertisement
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to prescriptions that can lead to administrative action from the DEA.
This video was recorded at the 2015 NCPA Annual Convention.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
US Vaccine Mandates During COVID-19 Did Not Raise Vaccination Rates, New Study Finds
2
Navigating Migraine Management and the Role of Symbravo in Acute Treatment
3
FDA Approves Enfortumab Vedotin Plus Pembrolizumab for Muscle-Invasive Bladder Cancer
4
Exposure to Fluoride in Tap Water Show No Cognitive Harm in Major Study
5




















































































































































































































